LIDOCAINE
- Product NDC
- 82927-001
- 11-digit product format
- 829270001
- Labeler code
- 82927
- Product ID
- 82927-001_e32f1a47-9a5c-73de-e053-2995a90a28a4
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- LIDOCAINE
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- CHENGDU DISCOUNT TRADING CO.LTD
- Application
- M015
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2022-08-08
- Marketing end
- 0000-00-00
- Substance
- LIDOCAINE
- Active strength
- 5 g/100g
- Pharmacologic classes
- Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 82927-001 | I | Inactivated by FDA | 2026-10-21 | ||
| excluded package | package | 82927-001 | 82927-001-01 | I | Inactivated by FDA | 2026-10-21 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 82927-001-01 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 82927-001-01 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 82927-001-01 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 82927-001-01 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 82927-001-01 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 82927-001-01 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 82927-001-01 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 82927-001-01 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 82927-001-01 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 82927-001-01 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 82927-001-01 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 82927-001-01 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 82927-001-01 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 82927-001-01 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 82927-001-01 | 1332a3947898… | d4bfe170f9cd… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 82927-001-01 | 2023-07-28 | C162847 | 48780-1 | 0191ceaa-6516-198a-e063-dbdaa90aec3e | 001 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 82927-001-01 | LIDOCAINE | 56 g in 1 BOX | CREAM | 56 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Revivol Hemorrhoid and Fissure | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Derma Care Research Labs, LLC | 0140cf68-b6a0-4378-e063-6394a90afee8 | 2024-12-19 | Warnings | M015 |
| Hemorroidal Cooling gel | PHENYLEPHRINE, WITCH HAZEL | Trifecta Pharmaceuticals Usa Llc | 651c0143-384c-3649-e053-2991aa0a0f28 | 2024-12-18 | Warnings | M015 |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | c50cc6ad-e8a0-47c1-e053-2a95a90a4de6 | 2024-12-18 | Warnings | M015 |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | fe18fa61-83f9-8bf9-e053-6294a90a7585 | 2024-12-18 | Warnings | M015 |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | c59dcb2a-392b-670b-e053-2995a90a9682 | 2024-12-18 | Warnings | M015 |
| TheraCare Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Veridian Healthcare | fab95657-d257-e671-e053-6294a90a59e0 | 2024-12-18 | Warnings | M015 |
| TN Dickinsons Witch Hazel Hemorrhoidal Pads | WITCH HAZEL | Dickinson Brands Inc. | 1b50f4dc-c26a-431a-ae18-c43513871b39 | 2024-12-18 | Warnings | M015 |
| RECTICARE | LIDOCAINE | Ferndale Laboratories, Inc. | 49cb48cf-7a26-4d7a-887f-2e98261d269d | 2024-12-17 | Warnings | M015 |
| Recticare Advanced | LIDOCAINE AND MINERAL OIL AND PHENYLEPHRINE HCL AND WHITE PETROLATUM | Ferndale Laboratories, Inc. | 209212a7-7b6e-4b26-9f31-0eeb76f026bf | 2024-12-17 | Warnings | M015 |
| RECTICARE | LIDOCAINE AND GLYCERIN | Ferndale Laboratories, Inc. | 2b94136a-4975-2925-e054-00144ff88e88 | 2024-12-17 | Warnings | M015 |
| PRAX | PRAMOXINE HYDROCHLORIDE | Ferndale Laboratories, Inc. | 674f0d8b-3d50-42b1-8401-d2967bcdf5cf | 2024-12-17 | Warnings | M015 |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Rugby | a5b5e0a9-eee9-2a1e-e053-2a95a90a464e | 2024-12-17 | Warnings | M015 |
| Warrior Rectal Care | LIDOCAINE 4%, PHENYLEPHRINE HYDROCHLORIDE 0.25% | Derma Care Research Labs | fc10cbc3-fc1b-ae09-e053-6394a90ac8f3 | 2024-12-15 | Warnings | M015 |
| Tucks Multi-Care Relief Kit (Tucks Hemorrhoidal and Tucks Medicated Cooling 40 Count) | GLYCERIN, LIDOCAINE, AND WITCH HAZEL | Blistex Inc | a7cb6d78-3048-43b3-afe7-4d862fdcfd3f | 2024-12-13 | Warnings | M015 |
| Tucks Medicated Cooling Pads | WITCH HAZEL | Blistex Inc | b3e68008-3d0d-4124-9579-b503e9fb95c9 | 2024-12-13 | Warnings | M015 |
| T.N. Dickinsons Witch Hazel Medicated Cooling Pads Hemorrhoidal Relief | WITCH HAZEL | Dickinson Brands Inc. | 2a4273a4-3bda-4653-a065-cd4578053f3c | 2024-12-12 | Warnings | M015 |
| Witch Hazel | WITCH HAZEL | Medical Products Laboratories, Inc. | b815792f-2f8f-7ac8-e053-2995a90ade18 | 2024-12-11 | Warnings | M015 |
| Zensa | LIDOCAINE | Alera Skin Care Products Inc. | f56146b6-3c11-4608-a6ab-6142f27e9ac3 | 2024-11-24 | Warnings | M015 |
| Hemorrhoid Pain Relief | LIDOCAINE | Telebrands Corp | 04164425-ca3b-ef24-e063-6294a90a59d8 | 2024-11-20 | Warnings | M015 |
| Hempvana Maximum Strength Pain Relief Topical Anesthetic | LIDOCAINE | Telebrands Corp | f525075a-d7ee-dad0-e053-2a95a90a6f3f | 2024-11-20 | Warnings | M015 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1534792 | lidocaine 5 % Topical Cream | PSN | e32f1a47-9a5b-73de-e053-2995a90a28a4 | 1 |
| 1534792 | lidocaine 50 MG/ML Topical Cream | SCD | e32f1a47-9a5b-73de-e053-2995a90a28a4 | 1 |
| 1534792 | lidocaine 5 % Topical Cream | SY | e32f1a47-9a5b-73de-e053-2995a90a28a4 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 82927-001-01 | 82927000101 | 56 g in 1 BOX (82927-001-01) | 56 g | 2022-08-08 | 0000-00-00 | No | No | Current |